A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

导出 LinkOut

翻译打印收藏纠错

作者： Stéphane,Jouneau ^[1] ; Anne-Sophie,Gamez ^[2] ; Julie,Traclet ^[3] ; Hilario,Nunes ^[4] ; Sylvain,Marchand-Adam ^[5] ; Romain,Kessler ^[6] ; Dominique,Israël-Biet ^[7] ; Raphael,Borie ^[8] ; Indiana,Strombom ^[9] ; Astrid,Scalori ^[10] ; Bruno,Crestani ^[8] ; Dominique,Valeyre ^[4] ; Vincent,Cottin ^[3]

作者单位： Respiratory Diseases Department, Pontchaillou Hospital, IRSET UMR 1085, Rennes 1 University, Rennes, France, stephane.jouneau@chu-rennes.fr. ^[1] Pulmonology, Montpellier University Hospital, Montpellier, France. ^[2] Pulmonology Department, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, France. ^[3] Pulmonology Department, Constitutive Site of the Reference Center for Rare Lung Diseases, Avicenne Hospital, Paris University 13, Bobigny, France. ^[4] Pulmonology Department, Tours Regional University Hospital, Tours, France. ^[5] Pulmonology, Strasbourg University Hospital, Strasbourg, France. ^[6] Pulmonology Department, Georges Pompidou European Hospital, AP-HP, Paris Descartes University, Paris, France. ^[7] Pulmonology Department, Bichat Hospital, Paris, France. ^[8] Genentech, San Francisco, California, USA. ^[9] Roche, Welwyn Garden City, United Kingdom. ^[10]

关键词 Daily practice Efficacy safety Idiopathic pulmonary fibrosis Pirfenidone

主题词老年人(Aged);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);女(雌)性(Female);法国(France);人类(Humans);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);吡啶酮类(Pyridones);时间因素(Time Factors);治疗结果(Treatment Outcome);肺活量(Vital Capacity)

DOI 10.1159/000496735

PMID 30965332

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Respiration; international review of thoracic diseases

19-28页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

Respiration; international review of thoracic diseases

相似文献

Respiration; international review of thoracic diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

Respiration; international review of thoracic diseases

相似文献

Respiration; international review of thoracic diseases

相关期刊

检索历史清除